Diagnostics & Informatics
The current state
as ofDiagnostics & Informatics is converging from separate test, imaging, and record-keeping markets into connected clinical data platforms that combine diagnostics, workflow software, and decision support. In 2026, strategic advantage is shifting toward vendors that can integrate multimodal data across labs, imaging, EHRs, and decentralized care settings while navigating tighter reimbursement, interoperability, and AI governance requirements.
What’s shaping Diagnostics & Informatics right now
- Decentralized testing is moving diagnostics into homes, pharmacies, and near-patient settings, forcing vendors to redesign logistics, quality control, and data integration architectures.
- Precision medicine demand is increasing the value of multi-omic, longitudinal, and therapy-linked diagnostics that can guide screening, stratification, and treatment selection.
- Interoperability mandates and buyer expectations are making seamless connectivity among LIS, PACS, EHRs, instruments, and cloud platforms a core procurement requirement.
- Reimbursement and procurement pressure is squeezing commoditized testing economics, pushing the market toward demonstrable clinical utility and outcome-linked value propositions.
- AI-specific regulation, privacy, and auditability requirements are shaping product design for diagnostic software, especially where algorithms influence clinical decisions.
Dynamics on the rise and in decline
Rising
Integrated diagnostics suites
Hospitals and labs are reducing tolerance for siloed point solutions across imaging, lab, and clinical workflows, driving demand for consolidated diagnostics-and-informatics platforms.
Pricing bifurcation
Routine assays and standardized testing are seeing procurement-driven margin compression, while specialty molecular, companion, and workflow-linked diagnostics maintain premium economics, widening the price gap.
Software-led value-chain shift
Control of the diagnostic value chain is moving to software, cloud, and data partners as EHR vendors, hyperscalers, and AI-native startups increasingly mediate interpretation, routing, and monetization of results.
This week’s brief
Earlier briefs
View all →Tracked trends
View all →- Platform Monetization — Diagnostics leaders are turning validated platforms into scalable revenue engines by selling the full stack, not just the test.
Deep dive
- What macro forces are shaping Diagnostics & Informatics in 2026?
- Diagnostics & Informatics in 2026 is being shaped by AI-driven workflow automation, the expansion of decentralized and remote testing, and rising demand for interoperable data systems. Precision medicine, multi-omics, and earlier detection are increasing the need to connect lab results with cloud platforms, EHRs, and real-world data. At the same time, affordability, reimbursement pressure, privacy, and regulatory compliance are slowing adoption and forcing vendors to prove clinical and economic value. The industry is also moving from standalone tools toward connected diagnostic ecosystems that support more continuous, proactive care.
- What major developments have reshaped diagnostics and informatics recently?
- In the last six months, diagnostics and informatics have been reshaped by rapid adoption of generative AI in imaging, lab workflows, and clinical documentation, moving these tools from pilots into core operations. Blood-based biomarkers and liquid biopsy capabilities have continued to advance, expanding earlier and less invasive detection options. Regulators and payers have also become more supportive of AI-enabled and digital diagnostic tools, which is accelerating commercialization. At the same time, diagnostics are moving more into at-home and mobile settings, changing how data is collected, interpreted, and delivered to clinicians and patients.
- What are the main competitive dynamics in diagnostics and informatics in 2026?
- In 2026, diagnostics and informatics are being shaped by consolidation, pricing pressure in commoditized testing, and a shift toward software- and data-driven value creation. Large incumbents are reshuffling portfolios through acquisitions and partnerships, while competition is intensifying from tech-enabled entrants, local-market challengers, and AI-focused startups. Pricing is falling in standardized testing and rising in differentiated specialty areas, especially where proprietary algorithms, multiplexing, and installed-base stickiness create defensible advantages. Business models are also moving from one-time product sales toward recurring SaaS, interoperability, and outcome-linked services.
- How are diagnostics and informatics being reshaped in 2026?
- Diagnostics and informatics in 2026 are being reshaped by AI-native tools, multimodal data platforms, remote and point-of-care testing, and advanced molecular and omics technologies. AI is increasingly embedded in imaging, pathology, lab workflows, and clinical decision support to improve triage, interpretation, and operational efficiency. Cloud-based, interoperable systems are connecting lab, imaging, EHR, and genomic data so providers can deliver faster, more personalized, and more proactive care. These shifts are also accelerating biomarker discovery, test development, and population-level analytics across the value chain.
- Who are the leading players in diagnostics and informatics today?
- The diagnostics and informatics market is led by large integrated incumbents that combine diagnostics revenues with lab software, imaging, and AI capabilities, including Roche, Thermo Fisher Scientific, Abbott, Danaher, Labcorp, Quest Diagnostics, Siemens Healthineers, GE HealthCare, Philips, Fujifilm, and Agilent. These companies dominate through scale, broad product portfolios, and deep relationships with hospitals, labs, and health systems. Challengers are increasingly coming from healthcare IT and clinical informatics vendors that add workflow, data, and decision-support layers to diagnostic operations. Emerging players are focused on AI, digital diagnostics, and lab informatics, often targeting narrower use cases with faster product cycles and software-first models.
- What developments signal major shifts in diagnostics and informatics?
- Major shifts in diagnostics and informatics are developments that change care settings, workflows, data control, or reimbursement models rather than simply adding new features. Examples include the move to decentralized and home-based testing, AI becoming embedded in end-to-end diagnostic workflows, cloud-native platforms that unify imaging and pathology data, and value-based reimbursement tied to clinical outcomes. Changes that expand diagnostics into continuous monitoring, pandemic response, or integrated ecosystem platforms also indicate structural change. By contrast, single-site pilots, narrow point solutions, and incremental product upgrades are usually routine noise.